Thousands of children living with diabetes may soon have a new treatment option that eliminates the need for needles.
Pierre Karl Péladeau, on behalf of Financière Outremont Inc. ("Financière Outremont"), holding nearly 10% of the shares of Transat A.T. Inc. ("Transat" or the "Company"), acknowledges the response ...
China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results